Comstock has completed the sale of its mining assets to Mackay Precious Metals, valuing the transaction at more than $45 million. The company has received $20 million in cash and shares currently valued at about $4.5 million, with a secured second-tranche payment of $7 million due within 18 months. Comstock expects to record a gain of approximately $10 million to $12 million and will retain a 1.5% net smelter return royalty.

ANZ expects the Bangko Sentral ng Pilipinas to lift its policy rate by 25 basis points to 5.0% at its Aug. 27 meeting to rein in inflation that remains above target. While headline inflation has eased over the past three months, July inflation of 6.2% is still well above the central bank’s 3%–4% goal. The BSP has raised rates twice this year, leaving the benchmark rate at 4.75%.

Gold miner Alkane reported FY26 net profit after tax of A$228.7 million, up 592% year on year. The result was driven by a 140% jump in gold production to 168,337 ounces from the Tomingley, Costerfield and Björkdal mines, alongside an average realised gold price of A$5,664 per ounce. Revenue rose 257% from a year earlier. The company ended the year with A$454 million in cash, bullion and listed investments.

Samsung Electronics plans to roll out a new shareholder return policy worth more than 100 trillion won later this month. The company is expected to allocate 50% of its free cash flow to the program as it looks to share record profits during an AI-driven chip supercycle. Rival SK Hynix has announced a 40 trillion won share buyback and cancellation plan that helped lift its stock 13% in one session.

MIT spinout SiTration and BHP, the world’s largest copper producer, have launched two pilots at the historic Copper Cities site in Arizona to test copper recovery technology. The mine produced nearly 400,000 tonnes of copper between the 1950s and the early 1980s. The projects aim to use existing resources to strengthen domestic supply chains while producing copper at the bottom of the global cost curve. Global copper demand is projected to rise by around 70% by 2050, driven by energy infrastructure and data-center buildouts.

Odysight.ai said it priced a public offering of 3,437,500 common shares at $3.20 per share. The company expects gross proceeds of about $11 million before underwriting discounts, commissions and offering expenses. Roth Capital Partners has a 30-day option to buy up to an additional 515,625 shares under an over-allotment option.

Edesa Biotech said it has priced an underwritten public offering of 3,870,500 common shares together with accompanying warrants, at a combined price of $5.50 per share. Certain investors may instead purchase prefunded warrants for up to 675,000 shares, with each prefunded warrant exercisable at $0.0001. Each common share or prefunded warrant is sold with an accompanying warrant.

Ascentage Pharma reported unaudited results for the first half of 2026, with revenue up 29% year over year to US$44.5 million, driven mainly by higher Olverembatinib sales. As of June 30, 2026, Olverembatinib had been added to formularies at 879 DTP pharmacies and hospitals. Hospital coverage rose 34% year over year to 394 hospitals.

WeTouch Technology reported results for the first half of fiscal year 2026, with total revenue of $30.3 million, up 9.4% year over year. Net income rose 25.5% to $6.0 million, and basic and diluted earnings per share increased to $0.50 from $0.40. Gross margin edged up to 35.3%, while operating cash flow increased to $5.5 million.